The 12th Board of Directors Meetings

Home»Investor Relation»Corporate Governance»Major Resolutions of Board Meetings
The 12th Board of Directors Meetings
Date Period Summary
2018.03.26 14
  • Status report on derivatives transactions from the previous period.
  • Approved FY2017 financial statements.
  • Approved independent CPA’s audit report to be issued for FY2017 financial statements.
  • Approved FY2017 business report.
  • Approved the effectiveness evaluation and the statement of declaration on the Company’s internal control system.
  • Approved the allocation of FY2017 distributable earnings.
  • Approved FY2017 distribution of employees' bonus and remuneration to Directors.
  • Approved amendments of major internal policies.
  • Approved donation to the Chinese National Association of Industry and Commerce (CNAIC).
  • Approved matters relating to FY2018 AGM.
  • Approved IFRS 16 implementation plan and preliminary evaluation of potential impacts.
  • Ratified credit limit applications from financial institutes.
2018.05.11 15
  • Status report on derivatives transactions from the previous period.
  • Approved internal audit report.
  • Approved Q1 FY2018 financial statements.
  • Approved independent auditor’s review report to be issued for Q1 FY2018 financial statements.
  • Approved proposal of cash capital increase for Quanta Venture Capital Co., Ltd.
  • Approved the 2017 CSR report.
  • Approved proposal of applying for syndication loans from financial institutes.
  • Ratified credit limit applications from financial institutes.
  • Approved donation to The SINOCON Industrial Standards Foundation
2018.07.10 16
  • Status report on derivatives transactions from the previous period.
  • Approved internal audit report.
  • Status report on the liability insurance for directors.
  • Approved base date for dividend disposition.
  • Approved adjustment of authorization on syndication loans.
  • Ratified credit limit applications from financial institutes.
2018.08.08 17
  • Status report on derivatives transactions from the previous period.
  • Approved internal audit report.
  • Approved 1H FY2018 financial statements.
  • Approved independent auditor’s review report to be issued for 1H FY2018 financial statements and.
  • Ratified credit limit applications from financial institutes.
2018.09.07 18
  • Status report on derivatives transactions from the previous period.
  • Approved internal audit report.
  • Approved FY2017 distribution of remuneration to management team.
  • Approved FY2017 distribution of remuneration to Directors.
  • Approved credit limit of short-term working capital needs for subsidiaries.
  • Ratified credit limit applications from financial institutes.
2018.11.13 19
  • Status report on derivatives transactions from the previous period.
  • Approved internal audit report.
  • Approved Q3 FY2018 financial statements.
  • Approved independent auditor’s review report to be issued for Q3 FY2018 financial statements.
  • Approved donation to the Chinese National Association of Industry and Commerce (CNAIC).
  • Approved proposal of land acquisitions.
  • Approved proposal of land and buildings acquisition.
  • Approved proposal of plant layout adjustment.
  • Approved the credit limit of short-term working capital needs for subsidiaries.
  • Ratified credit limit applications from financial institutes.
2018.12.21 20
  • Status report on derivatives transactions from the previous period.
  • Approved internal audit report.
  • Approved “2019 Annual Audit Plan” for the Company and its subsidiaries.
  • Approved 2019 CSR Strategy and Direction for the Company.
  • Approved annual assessment of accountants’ independence and professional qualifications.
  • Approved donation to Quanta Arts Foundation.
  • Approved 2018 annual bonus distribution plan for management team.
  • Approved application for “Pharmacist Manufacturing License” and “Pharmacist Selling License”
  • Approval the proposal to set up QTMC – Hwaya Site 2
  • Approved the credit limit of short-term working capital needs for subsidiaries.
  • Ratified credit limit applications from financial institutes.